// company-profile

Atara Biotherapeutics, Inc.

ATRA
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings92Insiders22
// api This Atara Biotherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares. Buying was led by Cherry Brian N.

// 90-day insight

Over the last 90 days, Atara Biotherapeutics, Inc. insiders bought $4.7M (5 transactions) and sold $3.2M (3 transactions).

  • Most active insider: EcoR1 Capital, LLC with 1 transaction totaling $4.7M.
  • Largest single purchase: $4.7M by EcoR1 Capital, LLC on May 7, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Atara Biotherapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$11.3M
QoQ change
-67.1%
Reporting period
2026-03-31
#1
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 1165408
$3.3M
700K shares
#2
Redmile Group, LLC
CIK 1425738
$2.1M
442K shares
#3
MACKENZIE FINANCIAL CORP
CIK 919859
$1.5M
314K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Cherry Brian NATRA
Award
24,000$0.00$0K
Jun 9, 2026HEIDEN WILLIAM KATRA
Award
12,000$0.00$0K
Jun 9, 2026Ciongoli Gregory AustinATRA
Award
12,000$0.00$0K
Jun 9, 2026Fust Matthew KATRA
Award
12,000$0.00$0K
May 18, 2026Nguyen AnhCoATRA
Sale
5,241$9.13$48K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.